Caspofungin Acetate
These highlights do not include all the information needed to use CASPOFUNGIN ACETATE FOR INJECTION safely and effectively. See full prescribing information for CASPOFUNGIN ACETATE FOR INJECTION. CASPOFUNGIN ACETATE for injection, for intravenous useInitial U.S. Approval: 2001
Approved
Approval ID
08fb61ee-a05a-4ce1-934c-8cd26c5733db
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 2, 2023
Manufacturers
FDA
Sagent Pharmaceuticals
DUNS: 080579617
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Caspofungin Acetate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code25021-194
Application NumberANDA207092
Product Classification
M
Marketing Category
C73584
G
Generic Name
Caspofungin Acetate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMay 2, 2023
FDA Product Classification
INGREDIENTS (5)
Caspofungin AcetateActive
Quantity: 5 mg in 1 mL
Code: VUW370O5QE
Classification: ACTIB
MannitolInactive
Code: 3OWL53L36A
Classification: IACT
Acetic AcidInactive
Code: Q40Q9N063P
Classification: IACT
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT
SucroseInactive
Code: C151H8M554
Classification: IACT
Caspofungin Acetate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code25021-195
Application NumberANDA207092
Product Classification
M
Marketing Category
C73584
G
Generic Name
Caspofungin Acetate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMay 2, 2023
FDA Product Classification
INGREDIENTS (5)
MannitolInactive
Code: 3OWL53L36A
Classification: IACT
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT
Acetic AcidInactive
Code: Q40Q9N063P
Classification: IACT
Caspofungin AcetateActive
Quantity: 7 mg in 1 mL
Code: VUW370O5QE
Classification: ACTIB
SucroseInactive
Code: C151H8M554
Classification: IACT